Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Antibiotics (Basel, Switzerland)|April 26, 2024
Characterizing Antibiotic Regimen Modification Behavior, Patient Characteristics, and Outcomes for Patients with Gram-Negative Bacterial Infections, A Retrospective Single-Center StudyJason Yamaki, Mirna Mikhail, Richard Beuttler, et al.
The Journal of Antimicrobial Chemotherapy|November 14, 2023
Incidence of acute kidney injury (AKI) and its impact on patient outcomes among adult hospitalized patients with carbapenem-resistant Gram-negative infections who received targeted treatment with a newer β-lactam or β-lactam/β-lactamase inhibitor-, polymyxin- or aminoglycoside-containing regimenThomas P Lodise, Emre Yucel, Engels N Obi, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 25, 2026
Clinical and Economic Outcomes Following First-Time Myocardial Infarction: A Nationwide Cohort Study from the SWEDEHEART RegistryChristian Reitan, Alexandre H Watanabe, Lori D Bash, et al.
Journal of the American Pharmacists Association : Japha|May 19, 2023
Clinical and economic implications of increasing access to herpes zoster vaccination rate in community pharmaciesAlexandre H Watanabe, Sajesh K Veettil, Lan My Le, et al.
The Annals of Pharmacotherapy|January 16, 2023
Evaluation of Safety and Efficacy of Intravenous Digoxin Loading Doses Based on Ideal Body WeightJessi L Clark, Joshua A Jacobs, Alexandre H Watanabe, et al.
Pulmonary Medicine|February 2, 2023
Patient Perspectives on the Use of Digital Technology to Help Manage Cystic FibrosisAlexandre H Watanabe, Connor Willis, Russell Ragsdale, et al.
Journal of Global Antimicrobial Resistance|April 8, 2024
Real-world evaluation of imipenem/cilastatin/relebactam across US medical centresRyan K Shields, Emre Yücel, Vladimir Turzhitsky, et al.
Scientific Reports|July 6, 2023
Impact of type of anticoagulant on clinical outcomes in cancer patients who had atrial fibrillationChatree Chai-Adisaksopha, Alexandre H Watanabe, Piyameth Dilokthornsakul, et al.
Journal of the American Pharmacists Association : Japha|May 6, 2021
A systematic review and meta-analysis of randomized controlled trials of cardiovascular toxicity of medical cannabinoidsAlexandre H Watanabe, Leenhapong Navaravong, Thitipong Sirilak, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2024
Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosaThomas P Lodise, Engels N Obi, Alexandre H Watanabe, et al.
Pageof 2